The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: Methyl 3-bromopropanoate( cas:3395-91-3 ) is researched.COA of Formula: C4H7BrO2.Mennie, Katrina M.; Vara, Brandon A.; Levi, Samuel M. published the article 《Reductive sp3-sp2 Coupling Reactions Enable Late-Stage Modification of Pharmaceuticals》 about this compound( cas:3395-91-3 ) in Organic Letters. Keywords: chloroaminopyrimidine bromide alkyl halide chemoselective cross electrophile reductive coupling. Let’s learn more about this compound (cas:3395-91-3).
Late-stage derivatization of pharmaceutically relevant scaffolds relies on the availability of highly functional-group tolerant reactions. Reactions that increase the sp3 character of mols. enable the pursuit of more selective and well-tolerated pharmaceuticals. Herein, we report the use of sp3-sp2 cross-electrophile reductive couplings to modify a generic ATP-competitive kinase inhibitor with a broad range of primary and secondary alkyl halide coupling partners.
In addition to the literature in the link below, there is a lot of literature about this compound(Methyl 3-bromopropanoate)COA of Formula: C4H7BrO2, illustrating the importance and wide applicability of this compound(3395-91-3).
Reference:
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem